Efficacy of High-Dose Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Glycemic Parameters in Patients With Type 2 Diabetes Estimated With Continuous Glucose Monitoring: A Pilot Study
Integrative Obesity and Diabetes
doi 10.15761/iod.1000176
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
Open Access Text Pvt, Ltd.